Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Vietnam Ophthalmic Drugs Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value & Volume
5.2. Market Share & Forecast
5.2.1. By Drug Class (Anti-Allergy, Anti-VEGF agents, Anti-inflammatory, Anti-glaucoma, Gene & Cell Therapy, and Others)
5.2.2. By Drug Disease (Dry Eye, Allergies, Glaucoma Infection, Retinal Disorders, Uveitis, Others)
5.2.3. By Route Of Administration (Topical, and Local Ocular)
5.2.4. By Dosage Type (Gels, Eye solutions & suspensions, Capsules & Tablets, Eye drops, and Ointments)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. Northern Vietnam Ophthalmic Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Class
6.2.2. By Drug Disease
6.2.3. By Route Of Administration
6.2.4. By Dosage Type
7. Central Vietnam Ophthalmic Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Class
7.2.2. By Drug Disease
7.2.3. By Route Of Administration
7.2.4. By Dosage Type
8. Southern Vietnam Ophthalmic Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Class
8.2.2. By Drug Disease
8.2.3. By Route Of Administration
8.2.4. By Dosage Type
9. Market Dynamics
9.1. Drivers
9.2. Challenges
10. Market Trends & Developments
10.1. Merger & Acquisition (If Any)
10.2. Product Launches (If Any)
10.3. Recent Developments
11. Policy & Regulatory Landscape
12. Vietnam Economic Profile
13. Vietnam Ophthalmic Drugs Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Bayer Vietnam Ltd.
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. DHG Pharmaceutical Joint Stock Company
15.3. Traphaco Joint Stock Company
15.4. Pharmaceutical Corporation Ha Tay
15.5. Domesco Medical Import Export Joint Stock Corporation (DOMESCO)
15.6. OPC Pharmaceutical Joint Stock Company
15.7. Sanofi-Aventis Vietnam
15.8. Mekophar Chemical and Pharmaceutical JSC
15.9. Merck Vietnam Company Ltd.
15.10. Pymepharco Joint Stock Company
16. Strategic Recommendations
17. About Us & Disclaimer